These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5032441)

  • 1. Biochemical evaluation of standard treatment with streptokinase in acute myocardial infarction.
    Gormsen J
    Acta Med Scand; 1972; 191(1-2):77-85. PubMed ID: 5032441
    [No Abstract]   [Full Text] [Related]  

  • 2. Single-blind randomised multicentre trial comparing heparin and streptokinase treatment in recent myocardial infarction.
    Amery A; Roeber G; Vermeulen HJ; Verstraete M
    Acta Med Scand Suppl; 1969; 505():1-35. PubMed ID: 4911123
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study on the use of fibrinolytics in the treatment of acute myocardial infarct. II. Personal experience].
    Saad EA; Kastansky I; Salek R
    Arq Bras Cardiol; 1972 Dec; 25(6):491-502. PubMed ID: 4660624
    [No Abstract]   [Full Text] [Related]  

  • 4. [Short-term fibrinolytic treatment in acute myocardial infarction].
    Breddin K; Ehrly AM; Fechler L; Frick D; König H; Kraft H; Krause H; Krzywanek HJ; Kutschera J; Lösch HW; Ludwig O; Mikat B; Rausch F; Rosenthal P; Sartory S; Voigt G; Wylicil P
    Dtsch Med Wochenschr; 1973 Apr; 98(17):861-73. PubMed ID: 4571884
    [No Abstract]   [Full Text] [Related]  

  • 5. [Streptokinase in myocardial infarct].
    Lasierra Cirujeda L; Viladés Juan E; Fernández Clemente JJ; Dulin Verde JJ; Moreno Resina B; Munilla García A; Macho Fernandez A; Fernandez De La Cigoña F
    Rev Clin Esp; 1977 Feb; 144(4):251-7. PubMed ID: 847260
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with the fibrinolytic treatment of the myocardial infarct].
    Neumann W; Bosseckert H; Müller S
    Z Gesamte Inn Med; 1968 Apr; 23(7):Suppl:107-10. PubMed ID: 5726419
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolytic treatment in acute myocardial infarct].
    Gormsen J
    Nord Med; 1971 Apr; 85(16):503-4. PubMed ID: 5573505
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombolytic therapy for acute myocardial infarction: circadian sensitivity].
    Kharash LM; Goldkhammer EI
    Ter Arkh; 1999; 71(12):13-7. PubMed ID: 10647192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in the plasma levels of fibrinopeptide A in acute myocardial infarction after administration of intravenous streptokinase].
    Amoriello A; Piantadosi FR; Piccenna L; Amoriello A; Vacca C; Eliseo V
    Cardiologia; 1988 Dec; 33(12):1121-6. PubMed ID: 3255497
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the use of fibrinolytic agents in the treatment of acute myocardial infarct. I. Basic principles, possibilities and limitations].
    Saad EA
    Arq Bras Cardiol; 1972 Oct; 25(5):427-38. PubMed ID: 4651966
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the effectiveness of the intravenous administration of streptokinase in acute myocardial infarction by monitoring the blood coagulation system].
    Stasiński T; Mazur-Cichocka M; Góreczna A
    Kardiol Pol; 1987; 30(10-11):626-31. PubMed ID: 3450941
    [No Abstract]   [Full Text] [Related]  

  • 12. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
    J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of streptokinase in acute evolving myocardial infarction].
    Bellotti G; Pileggi F; Barchi CA; Kajita LJ; Galiano N; Arié S; Rati M; Esteves Filho A; Silva LA; Garcia DP; Verginelli G; Décourt LV
    Arq Bras Cardiol; 1982 Jun; 38(6):433-8. PubMed ID: 7168673
    [No Abstract]   [Full Text] [Related]  

  • 14. Early experience with intravenous streptokinase in the treatment of acute myocardial infarction in Hilo Hospital.
    Lim DI
    Hawaii Med J; 1984 Nov; 43(11):394-6. PubMed ID: 6511388
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dosage and duration of the streptokinase treatment in myocardial infarct. Preliminary report].
    Weller P; Hanke P; Kujat G; Frank I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):33-7. PubMed ID: 4189369
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinolytic treatment of acute myocardial infarction. A preliminary report.
    Heikinheimo R; Ahrenberg P; Honkapohja H; Iisalo E; Kallio V; Konttinen Y; Leskinen O; Mustaniemi H; Reinikainen M; Siitonen L
    Adv Cardiol; 1970; 4():241-5. PubMed ID: 5493446
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute phase reaction following intravenous administration of streptokinase.
    Spöttl F; Kaiser R; Mosuni MS
    Thromb Diath Haemorrh; 1974 Jun; 31(3):429-34. PubMed ID: 4138217
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous streptokinase in acute myocardial infarction in Thai population.
    Tanomsup S; Suvachittanont O; Ratanaprakarn R; Tokavanich V; Palungwachira P
    J Med Assoc Thai; 1987 Feb; 70(2):79-84. PubMed ID: 3585214
    [No Abstract]   [Full Text] [Related]  

  • 19. Acylated streptokinase--plasminogen complex in patients with acute myocardial infarction.
    Walker ID; Davidson JF; Rae AP; Hutton I; Lawrie TD
    Thromb Haemost; 1984 Apr; 51(2):204-6. PubMed ID: 6377564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of infarct size with thrombolytic agents.
    Urban P; Gold HK; Goldberg S
    Cardiovasc Clin; 1983; 14(1):203-15. PubMed ID: 6225517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.